Given, particularly, the consistent upregulation of BSP and DSPP in prostate cancer, it is plausible to suggest that BSP and DSPP levels may predict progression of benign prostatic neoplasms to malignant disease. The gene discussed is IBSP; the disease is prostate carcinoma.